(Q44961461)

7 December 2017

title

Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial (English)

1 reference

7 December 2017

1 reference

2

Dennis M Black

1 reference

7 December 2017

Douglas C Bauer

1

1 reference

7 December 2017

Patrick Garnero

3

1 reference

7 December 2017

Marc Hochberg

4

1 reference

7 December 2017

Susan Ott

5

1 reference

7 December 2017

John Orloff

6

1 reference

7 December 2017

Desmond E Thompson

7

1 reference

7 December 2017

Susan K Ewing

8

1 reference

7 December 2017

Pierre D Delmas

9

1 reference

7 December 2017

Fracture Intervention Trial Study Group

10

1 reference

7 December 2017

publication date

24 May 2004

1 reference

Journal of Bone and Mineral Research

7 December 2017

published in

1 reference

7 December 2017

volume

19

1 reference

7 December 2017

issue

8

1 reference

7 December 2017

page(s)

1250-1258

1 reference

Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Antifracture efficacy of antiresorptive agents are related to changes in bone density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Clinical use of biochemical markers of bone remodeling: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Design of the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Vertebral fracture assessment using a semiquantitative technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

The role of bone turnover markers and risk factors in the assessment of osteoporosis and fracture risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Assessment of bone density and bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Mechanism of circadian variation in bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1359%2FJBMR.040512

21 January 2018

Identifiers

DOI

10.1359/JBMR.040512

1 reference

7 December 2017

1 reference